Episodios
-
Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.
-
Brian Kim, MD, had an unexpected attendee at one of his AAD sessions and delves into what's new, what's now, and what's next in atopic dermatitis management.
-
¿Faltan episodios?
-
Christopher Bunick, MD, PhD, associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut and Dermatology Times Editorial Advisory Board Member, caught up with us at the 2024 American Academy of Dermatology Meeting to decode new atopic dermatitis treatment data and how that translates to personalized options for patients.
-
Raj Chovatiya, MD, PhD, gives a sneak peek of what to expect in atopic dermatitis education at the 2024 American Academy of Dermatology (AAD) Meeting in San Diego, California March 8-12. Since the last meeting, the AAD has released new guidelines to treat the condition.
-
Nanette Silverberg, MD, clinical professor of pediatrics and dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, recently led the annual Revolutionizing Vitiligo (ReV) Virtual Conference. Discover what you need to say to overcome insurance coverage hangups with ruxolitinib, the importance of early intervention, and gain an overview of topical guidelines for patients of all ages with vitiligo.
-
This episode recaps a discussion during a recent Masterclasses in Dermatology Atopic Dermatitis meeting. Course Director Emmy Graber, MD, MBA, moderated a faculty Q&A after sessions. She asked leading atopic dermatitis experts about bathing routine advice for patients and families. They took different ages, cultures, and more into consideration. Rebecca Smith, MD; Lawrence Eichenfield, MD; Zakiya Pressley Rice, MD; and Christopher Bunick, MD, PhD; weighed in.
-
In this episode, discover and learn how to address the unique challenges faced by college students diagnosed with atopic dermatitis—especially as they navigate new lifestyles and medication management. Dr. Ruchi Gupta will lead a session on this topic at the 2023 American College of Allergy, Asthma, & Immunology Meeting in Anaheim, California.
-
In this episode, we delve into pediatric atopic dermatitis with Dr. Colleen Cotton from National Children’s Hospital in Washington, DC. She recently presented a session at Maui Derm NP+PA Fall 2023 in Asheville, North Carolina, and addressed the important considerations in children, why it is better to use an ointment as opposed to a cream, drugs available by age, the importance of timing with live vaccines, and the pros and cons of pre-filled syringes versus injectable pens for young patients.
-
Marty Makary, MD, MPH, FACS, is a professor at the Johns Hopkins University School of Medicine and Carey Business School, a member of the National Academy of Medicine, and a public health and public policy researcher. Makary is also a New York Times best-selling author of “Unaccountable: What Hospitals Won't Tell You and How Transparency Can Revolutionize Health Care,” and “The Price We Pay: What Broke American Health Care - And How to Fix it.” In this episode, Makary discusses the role of physician-led legislative advocacy in health care and dermatology, a topic he recently discussed in the keynote speech at the 2023 AADA Legislative Conference in Washington, DC, earlier this month.
-
In this episode, Jonathan Silverberg, MD, PhD, MPH, discusses of the effects of environmental pollutants on atopic dermatitis, including flares, severity, and recommendations for avoiding these pollutants when possible.
-
In this episode, Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University School of Medicine and the associate director of Clinical Trials at CCD Research, discusses what dermatologists and patients with atopic dermatitis can expect as we transition from winter to spring, as well as new and emerging treatments and technologies for managing atopic dermatitis that she’s looking ahead to as the year progresses.
-
In this episode, Christopher Bunick, MD, PhD, associate professor of dermatology at the Yale School Medicine, and a Dermatology Times Editorial Advisory Board member, discusses a paper he recently co-authored, titled “JAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies,” with Stefano Daniele, PhD candidate of the Medical Scientist Training Program at the Yale School of Medicine.
-
In this episode, we sit down with Bernard Cohen, MD, a professor of dermatology at Johns Hopkins University Pediatric Dermatology and Cutaneous Laser Center. He details new, emerging data in the world of atopic dermatitis and some new information on treating newborns and what patients should do now to battle the dry winter weather.
For additional news and insights, visit us at dermatologytimes.com -
On this episode of "The Cutaneous Connection", Bernard Cohen, MD, professor of pediatrics and dermatology at Johns Hopkins University School of Medicine, talks about how physicians and patients should treat atopic dermatitis in the winter months, and some new data on treating newborns.
For additional news and insights, visit us at dermatologytimes.com -
Today we're joined by Jeffrey M. Cohen, MD, a board-certified medical dermatologist and the director of the Psoriasis Treatment Program at the Yale School of Medicine. In this episode, he talks treatment options for adolescents with atopic dermatitis, how the changing seasons can affect flare-ups, and what caregivers can do at home to help prevent extreme itching.
For additional news and insights, visit us at dermatologytimes.com -
Peter Lio, MD, and clinical professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, discusses how atopic dermatitis presents differently in pediatric patients, and the 2021 allergen of the year, acetophenone azine associated with shin guard dermatitis.
For additional news and insights, visit us at dermatologytimes.com -
Raj Chovatiya, MD, PhD, and assistant professor of dermatology and director of the Center for Ecezma and Itch at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses the changing field of atopic dermatitis. He also talks about the importance of JAK inhibitors and the treatment options he looks forward to.
For additional news and insights, visit us at dermatologytimes.com -
Lawrence Eichenfield, MD, of Rady Children's Hospital-San Diego, who discusses the importance of multidisciplinary in the dermatology specialty. He gives his own experience with working with other specialties along with tips on how to improve communication with other health professionals.
-
In this episode, we sit down with Steven R. Feldman, MD, PhD, a dermatologist at Wake Forest Baptist Health, in North Carolina. Patient adherence to treatment, new treatments on the horizon for atopic dermatitis and more is discussed in this interview.
- Mostrar más